Aurora Cannabis Inc.
TSX:ACB.TODrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $414.85M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.32M
Average 0.42M
ACB.TO Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Aurora Cannabis Inc.TSX: ACB.TO
Depreciation & Amortization · Q4 FY2026 · quarter ended Mar 2026
Depreciation & amortization turns negative
Q4 FY2026 depreciation & amortization was -CA$4.62M, compared with CA$5.95M a year earlier. Trailing-twelve-month depreciation & amortization was CA$14.19M. Over 3 fiscal years it compounded at -31.2% a year.
Context
- Depreciation & amortization amounted to 4.4% of revenue in FY2026, down 2.1 pp from a year earlier.
- Depreciation & amortization increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near -CA$4.62M or moves back toward the trailing-twelve-month quarterly average of CA$3.55M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
CAD · from the cash flow
- Latest · FY2026
- 14.19M CAD
- Year-over-year change
- -37.1%
- 4-year CAGR
- -37.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 14.19M | -37.1% |
| FY2025 | 2025-03-31 | 22.55M | -31.8% |
| FY2024 | 2024-03-31 | 33.07M | -24.1% |
| FY2023 | 2023-03-31 | 43.57M | -53.5% |
| FY2022 | 2022-06-30 | 93.66M | — |
Depreciation & Amortization vs competitors
How ACB.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -37.1% is the lowest of 8, against a peer median of +1.6%.
- Depreciation & amortization amounts to 4.5% of revenue for ACB.TO, versus a peer median of 7.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$40.12M CAD | -6.9% | -23.0% | 12.9% | |
| LTM Mar 2026 | CA$19.76M CAD | +37.8% | — | 7.2% | |
| LTM Mar 2026 | $16.25M USD | -28.6% | -9.8% | 6.2% | |
| LTM Mar 2026 | CA$14.19M CAD | -37.1% | -31.2% | 4.5% | |
| LTM Mar 2026 | CA$11.86M CAD | +14.9% | -19.0% | 7.5% | |
| LTM Mar 2026 | $7.22M USD | +30.0% | +94.1% | 14.2% | |
| LTM Mar 2026 | CA$253K CAD | +1.6% | -2.8% | 9.2% | |
| LTM Mar 2026 | $101.93K USD | -1.0% | — | 0.2% | |
| Peer median (excluding ACB.TO) | — | +1.6% | -9.8% | 7.5% | |
Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | (1.72B) | (265.33M) | (59.05M) | 15.76M | (58.62M) |
| Depreciation & Amortization | 93.66M | 43.57M | 33.07M | 22.55M | 14.19M |
| Deferred Income Tax | (2.19M) | (18.4M) | (1.67M) | (3.19M) | 55K |
| Stock-Based Compensation | 13.76M | 16.89M | 12.72M | 11.52M | 7.29M |
| Change in Working Capital | 52.65M | (25.12M) | (15.63M) | 10.21M | (9.21M) |
| Accounts Receivables | 18.34M | 5.53M | (4.33M) | 5.24M | (8.15M) |
| Inventory | 21.07M | 49.03M | 3.62M | (15.05M) | 7.44M |
| Accounts Payables | 6.77M | (8.06M) | (15.7M) | 14.91M | (8.04M) |
| Other Working Capital | 6.48M | (71.61M) | 790K | 5.11M | (9.21M) |
| Other Non-Cash Items | 1.45B | 190.11M | (37.96M) | (40.85M) | 54.32M |
| Operating Cash Flow | (110.27M) | (115.82M) | (68.51M) | 16.01M | (13.51M) |
| Capital Expenditures | (32.21M) | (12.13M) | (16.96M) | (18.86M) | (22.55M) |
| Acquisitions (Net) | (23.42M) | (18.54M) | (5.55M) | 0 | 1.1M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 3.36M | 4.99M | 5.49M | 0 |
| Other Investing Activities | 19.46M | 16K | 12.02M | (956K) | (51.98M) |
| Investing Cash Flow | (36.17M) | (27.29M) | (5.49M) | (14.33M) | (73.43M) |
| Debt Repayment | (170.83M) | — | (85.76M) | (805K) | (5.02M) |
| Common Stock Issued | 350.19M | 73.19M | 37.93M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (31.58M) | (95.21M) | (89K) | 689K | (154K) |
| Financing Cash Flow | 147.78M | (56.48M) | (47.92M) | (116K) | 9.76M |
| Effect of Forex Changes | 15.01M | 15.54M | 297K | 264K | 4.33M |
| Net Change in Cash | 16.35M | (140.01M) | (121.5M) | 1.83M | (72.85M) |
| Free Cash Flow | (142.48M) | (127.95M) | (85.46M) | (2.85M) | (36.06M) |
Aurora Cannabis Inc.
TSX:ACB.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.